Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Immunol Res ; 72(2): 260-270, 2024 Apr.
Article in English | MEDLINE | ID: mdl-37924421

ABSTRACT

Autoantibodies are the hallmark of autoimmunity, and specifically, antinuclear antibodies (ANA) are one of the most relevant antibodies present in systemic autoimmune diseases (AID). In the present study, we evaluate the relationship between ANA and sociodemographic and biobehavioral factors in a population with a low pre-test probability for systemic AID. ANA were determined in serum samples at baseline visit from 2997 participants from the Camargo Cohort using indirect immunofluorescence assay, and two solid phase assays (SPA), addressable laser bead immunoassay, and fluorescence enzyme immunoassay. Sociodemographic and biobehavioral features of the subjects were obtained at baseline visit using a structured questionnaire. The prevalence of ANA positive results was significantly higher when indirect immunofluorescence assay was used as screening method in comparison with SPAs, being higher in females, older subjects, and those with higher C-reactive protein levels. Considering biobehavioral features, the prevalence was higher in those individuals with a sedentary lifestyle, and in ex- and non-alcohol users. Moreover, considering the relevance of the antibody load using ANA Screen, the prevalence of the antibody load also increased with age, especially in females. In conclusion, the prevalence of ANA varies depending on sociodemographic and biobehavioral features of the subjects, which could be relevant specifically in a population with a low pre-test probability for systemic AIDs.

2.
Clin Chem Lab Med ; 61(6): 1095-1104, 2023 05 25.
Article in English | MEDLINE | ID: mdl-36634098

ABSTRACT

OBJECTIVES: Autoantibodies and, specifically antinuclear antibodies (ANA), are the hallmark of systemic autoimmune diseases (AID). In the last decades, there has been great technical development to detect these autoantibodies along with an increased request for this test by clinicians, while the overall pre-test probability has decreased. In this study, we compare the diagnostic performance of three different methods for ANA screening (indirect immunofluorescence [IIF], addressable laser bead immunoassay [ALBIA], and fluorescence enzyme immunoassay [FEIA]). METHODS: Serum samples at baseline visit from 2,997 participants from the Camargo Cohort, a population with an overall low pre-test probability for systemic AID, were analyzed with the three methods. Participants have a minimum follow-up of 10 years and the development of autoimmune diseases was collected from clinical records. RESULTS: The highest frequency of positive ANA was observed by IIF assay. However, ALBIA showed high sensitivity for AID. Likewise, solid phase assays (SPA) presented higher specificity than IIF for AID. ANA prevalence with any method was significantly higher in females and overall increased with age. Triple positivity for ANA was significantly related to the presence of anti-dsDNA-SSA/Ro60, Ro52, SSB/La, RNP, Scl-70, and centromere-specificities. No association was found for anti-Sm - RNP68, or ribosomal P - specificities. Noteworthy, triple positivity for ANA screening was associated with diagnosis of systemic AID both at baseline visit and follow-up. CONCLUSIONS: ANA detection by IIF may be better when the pre-test probability is high, whereas SPA techniques are more useful in populations with an overall low pre-test probability for systemic AID.


Subject(s)
Antibodies, Antinuclear , Autoimmune Diseases , Female , Humans , Autoantibodies , Autoimmune Diseases/diagnosis , Fluorescent Antibody Technique, Indirect/methods , Immunoassay/methods
3.
Enferm Infecc Microbiol Clin (Engl Ed) ; 40(4): 190-194, 2022 04.
Article in English | MEDLINE | ID: mdl-35473990

ABSTRACT

BACKGROUND: Legionella is a well known but infrequent cause of bacterial endocarditis. METHODS: We report a case of endocarditis caused by Legionella spp. We reviewed previously reported cases in PubMed, Google Scholar and in references included in previous reports, and summarized relevant clinical data. RESULTS: A 63-year-old man with a history of aortic valve replacement developed persistent fever and monoarthritis. Transesophageal echocardiography showed perivalvular abscess. He died during surgery. Blood and valve cultures were negative. Legionella spp. was demonstrated with 16S-rRNA PCR from the resected material. Twenty cases of Legionella endocarditis have been reported. Harboring a prosthetic valve was the main risk factor. Prognosis was favorable, both for patients treated with or without surgical valve replacement. Overall mortality was <10%. CONCLUSIONS: Legionella is an infrequent cause of endocarditis. It frequently requires surgical treatment. Prognosis is good. Molecular techniques are likely to become the gold standard for diagnosis.


Subject(s)
Endocarditis, Bacterial , Endocarditis , Heart Valve Prosthesis , Legionella , Abscess/complications , Endocarditis, Bacterial/microbiology , Heart Valve Prosthesis/adverse effects , Humans , Male , Middle Aged
4.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 40(4): 1-5, Abril, 2022. ilus, tab
Article in English | IBECS | ID: ibc-203484

ABSTRACT

BackgroundLegionella is a well known but infrequent cause of bacterial endocarditis.MethodsWe report a case of endocarditis caused by Legionella spp. We reviewed previously reported cases in PubMed, Google Scholar and in references included in previous reports, and summarized relevant clinical data.ResultsA 63-year-old man with a history of aortic valve replacement developed persistent fever and monoarthritis. Transesophageal echocardiography showed perivalvular abscess. He died during surgery. Blood and valve cultures were negative. Legionella spp. was demonstrated with 16S-rRNA PCR from the resected material. Twenty cases of Legionella endocarditis have been reported. Harboring a prosthetic valve was the main risk factor. Prognosis was favorable, both for patients treated with or without surgical valve replacement. Overall mortality was <10%.ConclusionsLegionella is an infrequent cause of endocarditis. It frequently requires surgical treatment. Prognosis is good. Molecular techniques are likely to become the gold standard for diagnosis.


IntroducciónLegionella es una causa bien conocida, aunque infrecuente, de endocarditis bacteriana.MétodosA continuación, presentamos un caso de endocarditis por Legionella spp. Hemos revisado los casos publicados hasta la fecha en PubMed, Google Scholar y otras referencias incluidas en las comunicaciones previas, y resumimos aquí los datos clínicos relevantes. Un varón de 63 años con historia de recambio valvular aórtico desarrolló fiebre y monoartritis por lo que se realizó un ecocardiograma transesofágico que demostró un absceso perivalvular. Se decidió tratamiento quirúrgico, y el paciente falleció durante la cirugía. Los cultivos tanto de sangre como valvulares fueron negativos. El análisis mediante 16S rRNA PCR del material valvular resecado durante la cirugía demostró Legionella spp. Se han publicado un total de veinte casos de endocarditis por Legionella en la literatura médica. El principal factor de riesgo observado fue la presencia de una válvula protésica. El pronóstico fue bueno tanto para los pacientes tratados de manera conservadora como para aquellos sometidos a recambio valvular quirúrgico. La mortalidad global fue <10%.ConclusionesLegionella es una causa infrecuente de endocarditis. Generalmente requiere tratamiento quirúrgico. El pronóstico es bueno. Las técnicas moleculares podrían convertirse en el método de referencia para su diagnóstico.


Subject(s)
Humans , Male , Adult , Health Sciences , Endocarditis, Bacterial , Legionella , Blood Culture , Microbiology , Communicable Diseases , Case-Control Studies
5.
J Clin Endocrinol Metab ; 106(3): e1343-e1353, 2021 03 08.
Article in English | MEDLINE | ID: mdl-34932810

ABSTRACT

BACKGROUND: The role of vitamin D status in COVID-19 patients is a matter of debate. OBJECTIVES: To assess serum 25-hydroxyvitamin D (25OHD) levels in hospitalized patients with COVID-19 and to analyze the possible influence of vitamin D status on disease severity. METHODS: Retrospective case-control study of 216 COVID-19 patients and 197 population-based controls. Serum 25OHD levels were measured in both groups. The association of serum 25OHD levels with COVID-19 severity (admission to the intensive care unit, requirements for mechanical ventilation, or mortality) was also evaluated. RESULTS: Of the 216 patients, 19 were on vitamin D supplements and were analyzed separately. In COVID-19 patients, mean ±â€…standard deviation 25OHD levels were 13.8 ±â€…7.2 ng/mL, compared with 20.9 ±â€…7.4 ng/mL in controls (P < .0001). 25OHD values were lower in men than in women. Vitamin D deficiency was found in 82.2% of COVID-19 cases and 47.2% of population-based controls (P < .0001). 25OHD inversely correlates with serum ferritin (P = .013) and D-dimer levels (P = .027). Vitamin D-deficient COVID-19 patients had a greater prevalence of hypertension and cardiovascular diseases, raised serum ferritin and troponin levels, as well as a longer length of hospital stay than those with serum 25OHD levels ≥20 ng/mL. No causal relationship was found between vitamin D deficiency and COVID-19 severity as a combined endpoint or as its separate components. CONCLUSIONS: 25OHD levels are lower in hospitalized COVID-19 patients than in population-based controls and these patients had a higher prevalence of deficiency. We did not find any relationship between vitamin D concentrations or vitamin deficiency and the severity of the disease.


Subject(s)
COVID-19/blood , Vitamin D Deficiency/epidemiology , Vitamin D/analogs & derivatives , Aged , COVID-19/diagnosis , COVID-19/mortality , COVID-19/therapy , Case-Control Studies , Female , Hospital Mortality , Humans , Length of Stay/statistics & numerical data , Male , Middle Aged , Prevalence , Retrospective Studies , Severity of Illness Index , Vitamin D/blood , Vitamin D Deficiency/blood , Vitamin D Deficiency/diagnosis
6.
Eur J Case Rep Intern Med ; 8(10): 002821, 2021.
Article in English | MEDLINE | ID: mdl-34790623

ABSTRACT

Coronavirus disease 2019 (COVID-19) is currently a major public health problem. The development of pulmonary fibrosis secondary to acute respiratory distress syndrome (ARDS) is one of the expected sequelae. In this case series, we describe five instances of the use of anakinra in late-phase COVID-19 pneumonia in hospitalized patients with pulmonary fibrosis and refractory respiratory failure fulfilling ARDS criteria. The study demonstrates that anakinra has promising efficacy and safety in late-phase COVID-19 infection in patients with ARDS and refractory hypoxaemia, and suggests its potential application as antifibrotic therapy in these patients. LEARNING POINTS: Up to one third of patients with severe COVID-19 pneumonia progress to acute respiratory distress syndrome (ARDS).Pulmonary fibrosis is a known consequence of ARDS.Our study shows promising results regarding the efficacy and safety of anakinra used in late-phase COVID-19 infection in patients with pulmonary fibrosis secondary to ARDS.

7.
Galicia clin ; 82(3): 142-145, Julio-Agosto-Septiembre 2021. tab
Article in Spanish | IBECS | ID: ibc-221610

ABSTRACT

Se presenta un estudio observacional retrospectivo de todos los pacientes mayores 90 ingresados en un Servicio de Medicina Interna durante el año 2017, siendo seguidos durante un año para recabar los datos de mortalidad. Se incluyeron 932 pacientes, con una media de edad de 93,1 años (67,6% mujeres). La mediana de la estancia resultó de 7 días. Un 21,7% fallecieron durante el ingreso hospitalario. El porcentaje de reingresos en los primeros 30 días tras el alta fue del 8,4% y la mortalidad al año fue del 55,3%. Los pacientes nonagenarios representan un alto porcentaje de los ingresos en un Servicio de Medicina Interna; sin embargo, su estancia hospitalaria fue similar a la del resto de los pacientes ingresados y el número de reingresos precoces fue bajo. Sin embargo, su mortalidad al año fue elevada, especialmente durante el primer mes tras el alta. (AU)


Retrospective observational study of 90 years patients or older who were admitted to an Internal Medicine Service during 2017. Also followed up for one year after going home to collect mortality data. 932 patients were included, with a mean age of 93.1 years (67.6% women). The median stay was 7 days. In-hospital mortality was 21.7%. Readmissions in the first 30 days after discharge was 8.4% and mortality at one year was 55.3%. Nonagenarian represent a high percentage of patients in an Internal Medicine Service. The hospital stay was similar to other patients and the number of early readmissions was low. However, the mortality at first year was high, especially during the first month after discharge. (AU)


Subject(s)
Humans , Aged, 80 and over , Aged, 80 and over , Hospitalization , Internal Medicine , Mortality , Comorbidity
8.
Maturitas ; 148: 1-6, 2021 Jun.
Article in English | MEDLINE | ID: mdl-34024345

ABSTRACT

OBJECTIVE: To assess the association between the atherogenic index of plasma (AIP) and the trabecular bone score (TBS) in postmenopausal women. Furthermore, to analyze its relationship with bone mineral density (BMD), and serum concentrations of 25OHD, PTH, and bone turnover markers. STUDY DESIGN: Cross-sectional study nested in a population-based cohort of 1,367 postmenopausal women aged 44-94 years. Participants were classified according to TBS values (<1.230, between 1.230-1.310 and >1.310) and regarding a widely accepted cut-off point of ≥0.11 for AIP. We analyzed TBS, BMD, serum levels of 25OHD, PTH, P1NP, CTX, and clinical covariates. A multivariate analysis was performed to assess the adjusted association between AIP and TBS. RESULTS: The mean age of participants was 63±10 years. Women with TBS values <1.230 were older, had greater BMI, greater prevalence of fractures after the age of 40 years, more years since menopause, higher values of AIP, and significantly lower levels of HDL-C, serum phosphate, and 25OHD. AIP values ≥0.11 were not associated with the presence of densitometric osteoporosis (OR=0.83, 95%CI 0.58-1.18; p = 0.30) but, in multivariate analysis, AIP values ≥0.11 were related to a degraded microarchitecture after controlling for age, BMI, smoking, diabetes status, ischemic heart disease, statin use, GFR, a fragility fracture at over 40 years of age and lumbar osteoporosis by DXA, with an adjusted OR=1.61 (95%CI 1.06-2.46; p = 0.009). CONCLUSIONS: AIP is significantly and independently associated with a degraded bone microarchitecture as measured by TBS. In this sense, AIP might be a useful tool in the overall assessment of bone metabolism in postmenopausal women.


Subject(s)
Atherosclerosis/epidemiology , Bone Density , Cancellous Bone/pathology , Lumbar Vertebrae/pathology , Osteoporotic Fractures/epidemiology , Postmenopause , Absorptiometry, Photon , Adult , Aged , Aged, 80 and over , Atherosclerosis/blood , Atherosclerosis/pathology , Case-Control Studies , Cohort Studies , Cross-Sectional Studies , Female , Humans , Middle Aged , Osteoporotic Fractures/pathology , Spain/epidemiology
9.
J Clin Endocrinol Metab ; 106(3): e1343-e1353, 2021 03 08.
Article in English | MEDLINE | ID: mdl-33159440

ABSTRACT

BACKGROUND: The role of vitamin D status in COVID-19 patients is a matter of debate. OBJECTIVES: To assess serum 25-hydroxyvitamin D (25OHD) levels in hospitalized patients with COVID-19 and to analyze the possible influence of vitamin D status on disease severity. METHODS: Retrospective case-control study of 216 COVID-19 patients and 197 population-based controls. Serum 25OHD levels were measured in both groups. The association of serum 25OHD levels with COVID-19 severity (admission to the intensive care unit, requirements for mechanical ventilation, or mortality) was also evaluated. RESULTS: Of the 216 patients, 19 were on vitamin D supplements and were analyzed separately. In COVID-19 patients, mean ±â€…standard deviation 25OHD levels were 13.8 ±â€…7.2 ng/mL, compared with 20.9 ±â€…7.4 ng/mL in controls (P < .0001). 25OHD values were lower in men than in women. Vitamin D deficiency was found in 82.2% of COVID-19 cases and 47.2% of population-based controls (P < .0001). 25OHD inversely correlates with serum ferritin (P = .013) and D-dimer levels (P = .027). Vitamin D-deficient COVID-19 patients had a greater prevalence of hypertension and cardiovascular diseases, raised serum ferritin and troponin levels, as well as a longer length of hospital stay than those with serum 25OHD levels ≥20 ng/mL. No causal relationship was found between vitamin D deficiency and COVID-19 severity as a combined endpoint or as its separate components. CONCLUSIONS: 25OHD levels are lower in hospitalized COVID-19 patients than in population-based controls and these patients had a higher prevalence of deficiency. We did not find any relationship between vitamin D concentrations or vitamin deficiency and the severity of the disease.


Subject(s)
COVID-19/diagnosis , Vitamin D/blood , Aged , COVID-19/mortality , COVID-19/pathology , COVID-19/therapy , Case-Control Studies , Female , Hospital Mortality , Hospitalization/statistics & numerical data , Humans , Intensive Care Units/statistics & numerical data , Length of Stay/statistics & numerical data , Male , Middle Aged , Mortality , Prognosis , Respiration, Artificial/statistics & numerical data , Retrospective Studies , SARS-CoV-2/pathogenicity , Severity of Illness Index , Spain/epidemiology , Vitamin D Deficiency/blood , Vitamin D Deficiency/complications , Vitamin D Deficiency/mortality , Vitamin D Deficiency/therapy
10.
Article in English, Spanish | MEDLINE | ID: mdl-33376029

ABSTRACT

BACKGROUND: Legionella is a well known but infrequent cause of bacterial endocarditis. METHODS: We report a case of endocarditis caused by Legionella spp. We reviewed previously reported cases in PubMed, Google Scholar and in references included in previous reports, and summarized relevant clinical data. RESULTS: A 63-year-old man with a history of aortic valve replacement developed persistent fever and monoarthritis. Transesophageal echocardiography showed perivalvular abscess. He died during surgery. Blood and valve cultures were negative. Legionella spp. was demonstrated with 16S-rRNA PCR from the resected material. Twenty cases of Legionella endocarditis have been reported. Harboring a prosthetic valve was the main risk factor. Prognosis was favorable, both for patients treated with or without surgical valve replacement. Overall mortality was <10%. CONCLUSIONS: Legionella is an infrequent cause of endocarditis. It frequently requires surgical treatment. Prognosis is good. Molecular techniques are likely to become the gold standard for diagnosis.

11.
Rev. esp. geriatr. gerontol. (Ed. impr.) ; 54(5): 296-299, sept.-oct. 2019. tab
Article in Spanish | IBECS | ID: ibc-192716

ABSTRACT

El metotrexato es uno de los fármacos más empleados en pacientes con procesos reumatológicos, debido a su eficacia y perfil de seguridad. Sin embargo, los pacientes tratados con este fármaco son en ocasiones de edad avanzada, por lo que el riesgo de toxicidad aumenta, así como el de intoxicación por error en la toma de la medicación. Presentamos el caso de una paciente de 87 años, polimedicada, con antecedentes de deterioro cognitivo y escaso apoyo social que sufrió una intoxicación aguda grave por metotrexato. Además, describimos las características de los casos de toxicidad por este fármaco ingresados en nuestro Hospital en los últimos 7 años


Methotrexate is one of the most widely used drugs in rheumatology due to its high efficacy-to-toxicity. However, patients treated with this drug are sometimes elderly, which increases toxicity risks, as well as mistakes in taking the medication. The case is presented of an 87 year-old patient, on multiple medications, with a history of cognitive impairment and low social support, who suffered acute methotrexate toxicity. A description is also presented on the characteristics of the toxicity cases due this drug admitted to this hospital in the last 7 years


Subject(s)
Humans , Female , Aged, 80 and over , Antirheumatic Agents/poisoning , Methotrexate/poisoning , Severity of Illness Index , Time Factors
12.
Rev Esp Geriatr Gerontol ; 54(5): 296-299, 2019.
Article in Spanish | MEDLINE | ID: mdl-30992139

ABSTRACT

Methotrexate is one of the most widely used drugs in rheumatology due to its high efficacy-to-toxicity. However, patients treated with this drug are sometimes elderly, which increases toxicity risks, as well as mistakes in taking the medication. The case is presented of an 87 year-old patient, on multiple medications, with a history of cognitive impairment and low social support, who suffered acute methotrexate toxicity. A description is also presented on the characteristics of the toxicity cases due this drug admitted to this hospital in the last 7 years.


Subject(s)
Antirheumatic Agents/poisoning , Methotrexate/poisoning , Aged, 80 and over , Female , Humans , Severity of Illness Index , Time Factors
13.
J Bone Miner Metab ; 35(1): 114-121, 2017 Jan.
Article in English | MEDLINE | ID: mdl-26825659

ABSTRACT

Spinal osteoarthritis has been suggested as a risk factor for vertebral fractures. However, results are conflicting: most of the data are focused on the lumbar region, and referred to postmenopausal women, whereas data for men are scarce. The aim of this study is to assess the relationship between spinal osteoarthritis and vertebral fractures in men over 50 years of age. We conducted a cross-sectional study, nested in a prospective population-based cohort, including 507 community-dwelling men, 93 of them with at least one vertebral fracture. Vertebral fractures, osteophytosis, and disc space narrowing (DSN) were assessed by lateral thoracic and lumbar radiographs. Anthropometric, clinical, and densitometric variables were also analyzed. A multiple logistic regression model was performed. Eighty-five percent of vertebral fractures were located at the thoracic spine. Osteophytosis and DSN showed a bimodal distribution, with major frequency peaks at mid- and distal lumbar spine. The three distributions overlapped around the T9 vertebra. We did not find any relationship between lumbar osteoarthritis and vertebral fractures. Nevertheless, thoracic osteophytosis (OR, 1.84; 95 % CI, 1.05-3.17; p = 0.03) and DSN (OR, 2.52; 95 % CI, 1.43-4.46; p = 0.001) were found to be independently associated with prevalent vertebral fractures, after adjusting for confounders. Our results suggest a positive relationship between radiologic osteoarthritic changes at the thoracic spine and prevalent vertebral fractures in men more than 50 years of age. Osteoarthritis may act as a local risk factor, in addition to other mechanical factors, resulting in a greater propensity to fracture, especially at the mid-thoracic region.


Subject(s)
Lumbar Vertebrae , Osteoarthritis, Spine , Spinal Fractures , Spinal Osteophytosis , Thoracic Vertebrae , Aged , Cross-Sectional Studies , Female , Humans , Lumbar Vertebrae/diagnostic imaging , Lumbar Vertebrae/metabolism , Male , Middle Aged , Osteoarthritis, Spine/complications , Osteoarthritis, Spine/diagnostic imaging , Osteoarthritis, Spine/epidemiology , Osteoarthritis, Spine/metabolism , Prospective Studies , Spinal Fractures/diagnostic imaging , Spinal Fractures/epidemiology , Spinal Fractures/etiology , Spinal Fractures/metabolism , Spinal Osteophytosis/diagnostic imaging , Spinal Osteophytosis/epidemiology , Spinal Osteophytosis/etiology , Spinal Osteophytosis/metabolism , Thoracic Vertebrae/diagnostic imaging , Thoracic Vertebrae/metabolism
14.
Med. clín (Ed. impr.) ; 140(11): 493-499, jun. 2013. ilus, tab
Article in Spanish | IBECS | ID: ibc-112474

ABSTRACT

Fundamentos y objetivo: La edad parece modificar la relación entre el hipotiroidismo y la enfermedad cardiovascular (ECV). Si bien en sujetos muy ancianos el hipotiroidismo se ha asociado a longevidad, en las personas de ≤65 años el hipotiroidismo subclínico parece relacionarse con un mayor riesgo cardiovascular (RCV). El objetivo del estudio ha sido conocer la capacidad explicativa de la tirotropina plasmática (TSHp) para la ECV en diferentes estratos de edad (≤55, 56-74, ≥75 años), sexo y factores de RCV. Pacientes y método: Un total de 664 varones y mujeres son diferenciados en 18 estratos. Mediante regresión lineal múltiple se elaboran los 18 modelos explicativos. La variable dependiente es la calcificación aórtica abdominal (CAA), según la escala AAC-24. Las variables independientes son: TSHp, edad, hábito tabáquico, índice de masa corporal, presión arterial sistólica, presión arterial diastólica, glucemia basal, colesterol total, colesterol unido a lipoproteínas de alta densidad, colesterol unido a lipoproteínas de baja densidad y proteína C reactiva. Resultados: La edad es la principal variable explicativa de CAA. El mayor valor del coeficiente β estandarizado de la TSHp se observa en varones≤55 años (β=0,235, p=0,043) y en mujeres≥75 años (β=0,405, p=0,042). Al incrementarse la edad, la capacidad explicativa de la TSHp para la CAA aumenta en las mujeres y disminuye en los varones. En varones≥75 años hay una correlación negativa entre TSHp y CAA (rho-Spearman=-0,213, p=0,049). Conclusiones: Se observa una asociación positiva entre la TSHp y ECV en varones≤55 años y en mujeres≥75 años. La combinación de la regresión múltiple y el análisis estratificado ha mostrado la compleja influencia de la edad en la relación entre ambas variables (AU)


Background and objective: Age seems to modify the relationship between hypothyroidism and cardiovascular disease (CVD). Although hypothyroidism in very elderly subjects has been associated with longevity, subclinical hypothyroidism in people≤65 years seems to be related with an increased cardiovascular risk (CVR). The aim of this study was to determine the explanatory power of plasmatic TSH (pTSH) for the CVD, in different strata determined by age (≤55, 56-74, ≥75 years), sex and CVR factors. Patients and methods: Six hundred and sixty-four men and women were differentiated into 18 strata and their explanatory models were developed using the multiple linear regression analysis. The dependent variable is the abdominal aortic calcification (AAC) according to the AAC-24 scale. The independent variables are: pTSH, age, smoking, BMI, SBP, DBP, fasting glucose, total cholesterol, HDL-cholesterol, LDL-cholesterol and C-reactive protein. Results: Age is the main explanatory factor of AAC. The highest explanatory value of the β-standardized coefficient of the pTSH is observed in males≤55 years (β=0.235, P=.043) and in females≥75 years (β=0.405, P=.042). With increasing age, the prediction power improves in women and decreases in men. In men≥75 years there is a negative correlation between pTSH and AAC (rho-Spearman=-0.213, P=.049). Conclusions: A positive association is observed between pTSH and CVD in males≤55 years and in women≥75 years. The combination of multiple regression and the stratified analysis shows the complex influence of age in the relation between both variables (AU)


Subject(s)
Humans , Male , Female , Thyrotropin/blood , Hypothyroidism/physiopathology , Cardiovascular Diseases/epidemiology , Risk Factors , Age and Sex Distribution , Vascular Calcification/physiopathology , Regression Analysis , Aorta, Abdominal/physiopathology , C-Reactive Protein/analysis
15.
J Clin Endocrinol Metab ; 98(4): 1711-7, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23457409

ABSTRACT

OBJECTIVE: The aims of the study were to analyze whether there is an association between serum PTH and the prevalence of vertebral fractures and its possible dependence on vitamin D status, and to assess the influence of serum 25-hydroxyvitamin D (25OHD) in the relationship between PTH and bone mineral density (BMD) or bone turnover markers (BTMs). DESIGN, PARTICIPANTS, AND SETTING: A total of 820 postmenopausal women were recruited after excluding those with any known condition that could influence serum PTH levels, except for a possible low serum 25OHD. Serum PTH and 25OHD concentrations, as well as vertebral fracture prevalence, BMD, and BTM (CTX and PINP) values were recorded. Serum PTH levels were divided into tertiles, and women were grouped into those in the highest tertile (>58 pg/ml) and those below. Serum 25OHD levels were stratified in 3 categories (<20, 20-30, and >30 ng/ml). RESULTS: Vertebral fracture prevalence was greater in women with PTH above 58 pg/ml (odds ratio [OR], 1.72; 95% confidence interval [CI], 1.04-2.84). After stratifying by 25OHD, this difference was only significant in women below 20 ng/ml (OR, 2.00; 95% CI, 1.02-3.87), those with 25OHD between 20 and 30 ng/ml showing a trend toward this (OR, 1.99; 95% CI, 0.92-4.36). Differences in BMD or BTM between women above and below 58 pg/ml of PTH were also observed only in those below 20 ng/ml. CONCLUSION: Elevated PTH levels are associated with increased prevalence of vertebral fractures, low bone mass, or higher BTM only in the presence of hypovitaminosis D. An adequate nutritional status in the vitamin appears to protect the bone from the deleterious effect of a high PTH.


Subject(s)
Biomarkers/blood , Bone Density/physiology , Bone Remodeling/physiology , Parathyroid Hormone/blood , Postmenopause/blood , Spinal Fractures/blood , Vitamin D/blood , Aged , Biomarkers/metabolism , Calcium/blood , Female , Humans , Middle Aged , Nutritional Status , Postmenopause/metabolism , Prevalence , Risk Factors , Spinal Fractures/epidemiology , Spinal Fractures/etiology , Spine/metabolism , Spine/pathology
16.
Med Clin (Barc) ; 140(11): 493-9, 2013 Jun 04.
Article in Spanish | MEDLINE | ID: mdl-22717352

ABSTRACT

BACKGROUND AND OBJECTIVE: Age seems to modify the relationship between hypothyroidism and cardiovascular disease (CVD). Although hypothyroidism in very elderly subjects has been associated with longevity, subclinical hypothyroidism in people ≤ 65 years seems to be related with an increased cardiovascular risk (CVR). The aim of this study was to determine the explanatory power of plasmatic TSH (pTSH) for the CVD, in different strata determined by age (≤ 55, 56-74, ≥ 75 years), sex and CVR factors. PATIENTS AND METHODS: Six hundred and sixty-four men and women were differentiated into 18 strata and their explanatory models were developed using the multiple linear regression analysis. The dependent variable is the abdominal aortic calcification (AAC) according to the AAC-24 scale. The independent variables are: pTSH, age, smoking, BMI, SBP, DBP, fasting glucose, total cholesterol, HDL-cholesterol, LDL-cholesterol and C-reactive protein. RESULTS: Age is the main explanatory factor of AAC. The highest explanatory value of the ß-standardized coefficient of the pTSH is observed in males ≤ 55 years (ß=0.235, P=.043) and in females ≥ 75 years (ß=0.405, P=.042). With increasing age, the prediction power improves in women and decreases in men. In men ≥ 75 years there is a negative correlation between pTSH and AAC (rho-Spearman=-0.213, P=.049). CONCLUSIONS: A positive association is observed between pTSH and CVD in males ≤ 55 years and in women ≥ 75 years. The combination of multiple regression and the stratified analysis shows the complex influence of age in the relation between both variables.


Subject(s)
Cardiovascular Diseases/blood , Thyrotropin/blood , Age of Onset , Aged , Aged, 80 and over , Aging/physiology , Aortic Aneurysm, Abdominal/epidemiology , C-Reactive Protein/analysis , Calcinosis/epidemiology , Cardiovascular Diseases/epidemiology , Comorbidity , Cross-Sectional Studies , Dyslipidemias/epidemiology , Female , Humans , Hyperglycemia/epidemiology , Hypertension/epidemiology , Hypothyroidism/blood , Hypothyroidism/epidemiology , Inflammation/blood , Inflammation/epidemiology , Linear Models , Male , Middle Aged , Models, Cardiovascular , Osteoporosis/blood , Osteoporosis/epidemiology , Postmenopause/blood , Risk Factors , Smoking/epidemiology , Spain/epidemiology
17.
J Clin Endocrinol Metab ; 97(12): 4491-7, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23043189

ABSTRACT

OBJECTIVE: Our objective was to know the extent to which a fall in bone turnover markers is influenced by serum 25-hydroxyvitamin D (25OHD) levels in patients on alendronate (ALN) treatment. DESIGN, PARTICIPANTS, AND SETTING: A total of 140 postmenopausal osteoporotic women were randomized to receive either ALN or ALN plus 25OHD(3) (ALN+VitD) over a 3-month period. Serum 25OHD, PTH, C-terminal telopeptide of type I collagen (CTX), and amino-terminal propeptide of type I collagen (P1NP) were measured at baseline and at the end of the 3 months. RESULTS: 25OHD rose four times above baseline levels in the ALN+VitD group, whereas no changes were seen in the ALN group. Administering ALN resulted in a significant decline in both serum CTX (53 ± 24%) and P1NP (46 ± 19%). After ALN+VitD, the fall in CTX amounted to 61 ± 20% (P = 0.06 compared with ALN) and P1NP to 50 ± 23% (P = 0.35). When patients were divided into those below and above 20 ng/ml of baseline serum 25OHD, in those below, CTX decreased by 48 ± 26% in the ALN group and by 61 ± 17% in the ALN+VitD group (P = 0.015). For P1NP, the corresponding figures were 43 ± 20 and 50 ± 23% (P = 0.2). In patients above 20 ng/ml, no differences were seen regarding CTX (58 ± 21% decrease in the ALN group and 60 ± 23% in the ALN+VitD group; P = 0.7) or P1NP (49 ± 18 and 50 ± 20%; P = 0.9). CONCLUSIONS: Administration of 25OHD(3) is not an indispensable requirement for bisphosphonates to develop their bone antiresorptive effect. In fact, in patients with vitamin D sufficiency, no benefit is observed when the vitamin is added. However, in patients with vitamin D deficiency, an approximately 25% greater fall in the bone resorption marker CTX is seen with its administration.


Subject(s)
Alendronate/therapeutic use , Biomarkers/blood , Bone Remodeling/drug effects , Calcifediol/pharmacology , Osteoporosis, Postmenopausal/drug therapy , Parathyroid Hormone/blood , Aged , Alendronate/administration & dosage , Biomarkers/analysis , Bone Density/drug effects , Bone Density Conservation Agents/administration & dosage , Bone Density Conservation Agents/therapeutic use , Calcifediol/administration & dosage , Calcifediol/blood , Drug Combinations , Drug Interactions , Female , Humans , Middle Aged , Osteoporosis, Postmenopausal/blood , Treatment Outcome
18.
Rev Esp Quimioter ; 24(4): 217-22, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22173193

ABSTRACT

OBJECTIVES: To assess the incidence and risk factors for nosocomial infection after video-assisted thoracic surgery (VATS). METHODS: Prospective cohort study of all consecutive patients who underwent VATS surgery during 20 months. Patients were visited on a daily basis and followed up until they were discharged from the hospital. RESULTS: During the study period 217 patients (70.1% men; mean age, 50.9 years, range 15-85 years) underwent VATS. Fourteen (6%) episodes of postoperative infection were diagnosed in 13 patients, including pneumonia (n = 2), lower respiratory tract infection (n = 9), surgical site infection (n = 2), and urinary tract infection (n = 1). Prior inmunosupresion (adjusted odds ratio [OR], 2.70; 95% confidence interval [CI], 1.52-4.84), prior infections (OR, 14.9; 95% CI 1.91-116.5), preoperative stay > 2 days (OR, 3.37; 95% CI 1.00-11.40), neoplasia (OR, 3.69; 95% CI, 1.94-7.06) duration of surgery > 45 minutes (OR, 5.91; 95% CI, 1.00-36.40) and presence of central venous catheter (OR, 16.40; 95% CI, 2.29-117.20), were independent risk factors for nosocomial infection. CONCLUSIONS: Nosocomial infection rate after VATS was low. Respiratory infection was the most common infection. Factors which affect patient immunity, preoperative stay and perioperative-related variables were independently associated with infection.


Subject(s)
Cross Infection/epidemiology , Cross Infection/etiology , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Thoracic Surgery, Video-Assisted/adverse effects , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Antibiotic Prophylaxis/statistics & numerical data , Confidence Intervals , Data Collection , Data Interpretation, Statistical , Female , Humans , Immunosuppressive Agents/adverse effects , Male , Middle Aged , Odds Ratio , Prospective Studies , Risk Factors , Sex Factors , Smoking/adverse effects , Spain/epidemiology , Young Adult
19.
Rev. esp. quimioter ; 24(4): 217-222, dic. 2011. tab
Article in English | IBECS | ID: ibc-93789

ABSTRACT

Objetivos: Estudiar la incidencia y los factores de riesgo de infección nosocomial en pacientes sometidos a una cirugía toracoscópica videoasistida. Métodos: Estudio de cohortes prospectivo de todos los pacientes a los que se practicó una toracoscopia videoasistida durante 20 meses consecutivos. Los pacientes se visitaron diariamente hasta ser dados de alta hospitalaria. Resultados: Durante el periodo de estudio se le practicó una toracoscopia videoasistida a 217 pacientes (70,1% hombres; edad media: 50,9 años, rango, 15-85 años). Se diagnosticaron 14 (6%) infecciones en 13 pacientes: 9 desarrollaron una infección de vías respiratorias bajas, 2 neumonía, 2 infección del sitio quirúrgico y 1 infección urinaria. En el análisis de regresión logística el tener una inmusupresión previa, (odds ratio [OR] ajustada: 2,70; intervalo de confianza [IC] 95%, 1,52- 4,84), infección previa (OR: 14,9; IC 95% 1,91-116,5), estancia preoperatoria > 2 días (OR: 3,37; IC 95% 1,00-11,40), neoplasia (OR: 3,69; IC 95%, 1,94-7,06), duración de la cirugía > 45 minutes (OR: 5,91; IC 95%, 1,00-36,40) y la presencia de catéter venoso central (OR: 16,40; IC 95%, 2,29-117,20), se comportaron como factores independientes de riesgo de infección nosocomial. Conclusiones: La tasa de infección nosocomial después de una cirugía toracoscópica videoasistida es baja. Las infecciones respiratorias fueron las más frecuentes. Los factores de riesgo independientes fueron los relacionados con la inmunidad previa del paciente, la estancia prequirúrgica y el momento perioperatorio(AU)


Objectives: To assess the incidence and risk factors for nosocomial infection after video-assisted thoracic surgery (VATS). Methods: Prospective cohort study of all consecutive patients who underwent VATS surgery during 20 months. Patients were visited on a daily basis and followed up until they were discharged from the hospital Results: During the study period 217 patients (70.1% men; mean age, 50.9 years, range 15-85 years) underwent VATS. Fourteen (6%) episodes of postoperative infection were diagnosed in 13 patients, including pneumonia (n = 2), lower respiratory tract infection (n = 9), surgical site infection (n = 2), and urinary tract infection (n = 1). Prior inmunosupresion (adjusted odds ratio [OR], 2.70; 95% confidence interval [CI], 1.52-4.84), prior infections (OR, 14.9; 95% CI 1.91-116.5), preoperative stay > 2 days (OR, 3.37; 95% CI 1.00-11.40), neoplasia (OR, 3.69; 95% CI, 1.94-7.06) duration of surgery > 45 minutes (OR, 5.91; 95% CI, 1.00-36.40) and presence of central venous catheter (OR, 16.40; 95% CI, 2.29-117.20), were independent risk factors for nosocomial infection. Conclusions: Nosocomial infection rate after VATS was low. Respiratory infection was the most common infection. Factors which affect patient immunity, preoperative stay and perioperative-related variables were independently associated with infection(AU)


Subject(s)
Humans , Male , Female , Cross Infection/drug therapy , Thoracoscopy/adverse effects , Thoracoscopy , Immunosuppression Therapy/methods , Immunosuppression Therapy , Risk Factors , Cross Infection/epidemiology , Cross Infection/prevention & control , Prospective Studies , Cohort Studies , Odds Ratio
20.
Maturitas ; 69(2): 162-7, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21454025

ABSTRACT

OBJECTIVES: To compare bone parameters measured by calcaneous quantitative ultrasonography (BUS) in subjects with and without metabolic syndrome (MetS). In addition, we wanted to examine the association of each of the individual components of the syndrome with BUS measurements, to study the relationship between calciotropic hormones or bone turnover markers with BUS parameters in subjects with or without MetS, and to explore the possibility that the relationship between prevalent vertebral and non-vertebral fractures and BUS is influenced by MetS status. STUDY DESIGN: Cross-sectional study. RESULTS: We investigated 1209 (421 men and 788 women) participants from the Camargo Cohort Study. Prevalence of MetS was 27% in men and 31% in women. Women, but not men, with MetS had higher age-adjusted BUS parameters compared with those without (p<0.05), the difference disappearing after adjustment for BMI. Out of the five single components of MetS, only waist perimeter was significantly associated with BUS (p<0.01), the association being restricted to women. In men and women with MetS (but not without) a positive significant association was observed between BUS and 25OHD levels. BUS parameters were associated with serum P1NP or CTX in normal women, but not in those with MetS. Prevalent vertebral and non-vertebral fractures and BUS parameters (BUA and SOS, respectively) are inversely associated, but this relationship, however, is not influenced by MetS status. CONCLUSIONS: BUS parameters are higher in women with MetS, and this difference disappears after adjusting for BMI. MetS status did not influence the relationship between BUS parameters and vertebral or non-vertebral fractures.


Subject(s)
Bone Density , Bone Remodeling/physiology , Calcaneus/diagnostic imaging , Metabolic Syndrome/complications , Osteoporosis/complications , Aged , Biomarkers/blood , Body Mass Index , Cohort Studies , Cross-Sectional Studies , Female , Fractures, Bone/diagnostic imaging , Humans , Male , Metabolic Syndrome/diagnostic imaging , Metabolic Syndrome/epidemiology , Middle Aged , Osteoporosis/blood , Osteoporosis/diagnostic imaging , Prevalence , Sex Factors , Ultrasonography , Vitamin D/analogs & derivatives , Vitamin D/blood , Waist Circumference
SELECTION OF CITATIONS
SEARCH DETAIL
...